Price
No data yet.
Social Signal Score
Analyst Ratings
3 analystsRevenue
$12.19M+99.36%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Stephen Gunstream
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 158
- Beta
- 0.73
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- 6.81
Financials
Revenue
$12.19M+99.4%Net Income
$-3.17M-434.4%EBITDA
$-1.29M-188.4%Free Cash Flow
$-596.0KEPS (diluted)
$-0.06-889.5%Shares Outstanding (diluted)
53.63M+1374.8%Operating Expenses
$7.49MCash & Debt
$17.44MReturn of Capital
$0.00Revenue by Segment (annual)
$40.52MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $40.52M | $-17.26M | $-0.32 |
| 2024 | $37.74M | $-26.75M | $-0.57 |
| 2023 | $36.68M | $-36.78M | $-1.16 |
| 2022 | $41.42M | $-47.47M | $-1.69 |
| 2021 | $36.89M | $-9.80M | $-0.35 |
| 2020 | $31.30M | $3.57M | $0.16 |
| 2019 | $20.09M | $-1.30M | $-0.36 |
Valuation
TKNOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
10-93.75%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·3d ago·Negative
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System Teknova and Pluristyx announce a Type II FDA Drug Master File for the PluriFreeze™ cryopreservation system, now available to developers for cross-reference
View source ↗ - Newszacks.com·4d ago·Positive
All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy Alpha Teknova (TKNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newsdefenseworld.net·11d ago·Negative
88,412 Alpha Teknova, Inc. $TKNO Shares Sold by Squarepoint Ops LLC Squarepoint Ops LLC reduced its stake in shares of Alpha Teknova, Inc. (NASDAQ: TKNO) by 71.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,948 shares of the company's stock after selling 88,412 shares during the quarter. Squarepoint
View source ↗ - Newszacks.com·14d ago·Neutral
Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last? Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling Teknova's Fill-Tek™ Dispensing System fills single-use bag orders across multiple sizes and quantities as a single lot, with no added turnaround time.
View source ↗ - Newsmarketbeat.com·47d ago·Neutral
Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference Alpha Teknova NASDAQ: TKNO Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve.
View source ↗ - Newszacks.com·47d ago·Positive
Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy? Does Alpha Teknova (TKNO) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $-0.06 per share
Typical surprise +14.7% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$-0.06 vs $-0.08beat
- Wed, May 6$-0.08 vs $-0.09beat
- Thu, Feb 26$-0.09 vs $-0.09beat
- Thu, Nov 6$-0.08 vs $-0.09beat
- Thu, Aug 7$-0.07 vs $-0.10beat
- Thu, May 8$-0.09 vs $-0.11beat
Estimates and results for TKNO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by TKNO officers and directors.
- Bought
- $32.7m
- Sold
- $101k
34 trades
4 trades
- Lowell Matthewbought
- Gunstream Stephenbought
- Demski Martha Jsold
- Telegraph Hill Partners Iv, L.p.bought
- Telegraph Hill Partners Iv, L.p.bought
- Lowell Matthewbought
- Gunstream Stephenbought
- Gelhaus Kenbought
62 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (39d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (25d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (34d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (34d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (26d later)Sell$15,001 - $50,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (25d later)Sell$15,001 - $50,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (22d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (41d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (41d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (33d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (33d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (27d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (27d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (43d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (34d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (33d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (27d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 1, 2026 (29d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.